David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$510M |
| 2 |
Bank of America
BAC
|
+$395M |
| 3 |
Meta Platforms (Facebook)
META
|
+$365M |
| 4 |
Costco
COST
|
+$351M |
| 5 |
Procter & Gamble
PG
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$573M |
| 2 |
Advanced Micro Devices
AMD
|
+$405M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$387M |
| 4 |
Walmart Inc
WMT
|
+$364M |
| 5 |
Amazon
AMZN
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.38% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 7.82% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Communication Services | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSDA
2251
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
| $3.98M | ﹤0.01% |
406,517
| – | – |
|
|
LIBY
2252
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
| $3.98M | ﹤0.01% |
397,454
| – | – |
|
|
CFFS
2253
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $3.98M | ﹤0.01% |
400,000
+266,667
| +200% | +$2.65M |
|
2254
GrowGeneration
GRWG
$101M
| $3.97M | ﹤0.01% |
1,106,207
+469,464
| +74% | +$2.68M |
|
|
GGMC
2255
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
| $3.97M | ﹤0.01% |
407,664
| – | – |
|
|
KLAQ
2256
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
| $3.97M | ﹤0.01% |
403,429
+50,115
| +14% | +$492K |
|
2257
PUT
Cummins
CMI
$79.5B
| $3.97M | ﹤0.01% |
20,500
-3,700
| -15% | -$740K |
|
|
CLRM
2258
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
| $3.97M | ﹤0.01% |
403,864
+50,061
| +14% | +$491K |
|
2259
PUT
Kinross Gold
KGC
$38.3B
| $3.96M | ﹤0.01% |
1,107,500
+118,000
| +12% | +$571K |
|
|
IAS
2260
DELISTED
Integral Ad Science
IAS
| $3.96M | ﹤0.01% |
398,943
+26,473
| +7% | +$316K |
|
2261
Coherus Oncology
CHRS
$212M
| $3.96M | ﹤0.01% |
546,665
+180,878
| +49% | +$1.57M |
|
2262
Gaotu Techedu
GOTU
$413M
| $3.96M | ﹤0.01% |
2,017,770
+528,895
| +36% | +$848K |
|
2263
Landstar System
LSTR
$6.14B
| $3.95M | ﹤0.01% |
27,184
+8,961
| +49% | +$1.33M |
|
2264
CALL
Gilead Sciences
GILD
$184B
| $3.95M | ﹤0.01% |
63,900
-533,700
| -89% | -$33M |
|
2265
Ares Management
ARES
$32.2B
| $3.95M | ﹤0.01% |
+69,432
| New | +$4.8M |
|
|
SHAC
2266
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $3.94M | ﹤0.01% |
402,144
+135,644
| +51% | +$1.33M |
|
2267
Stratasys
SSYS
$702M
| $3.93M | ﹤0.01% |
209,699
-17,054
| -8% | -$336K |
|
2268
RLJ Lodging Trust
RLJ
$1.75B
| $3.93M | ﹤0.01% |
356,165
-138,581
| -28% | -$1.81M |
|
2269
Quanex
NX
$906M
| $3.93M | ﹤0.01% |
172,615
-80,143
| -32% | -$1.67M |
|
2270
Rigel Pharmaceuticals
RIGL
$868M
| $3.93M | ﹤0.01% |
347,454
+294,081
| +551% | +$5.91M |
|
2271
Ormat Technologies
ORA
$6.39B
| $3.92M | ﹤0.01% |
+50,092
| New | +$3.95M |
|
|
ONIT
2272
Onity Group
ONIT
$287M
| $3.92M | ﹤0.01% |
143,213
-4,369
| -3% | -$103K |
|
|
VIEW
2273
DELISTED
View, Inc. Class A Common Stock
VIEW
| $3.92M | ﹤0.01% |
40,280
+30,069
| +294% | +$2.67M |
|
2274
TriSalus Life Sciences
TLSI
$304M
| $3.91M | ﹤0.01% |
397,506
+204,867
| +106% | +$2.01M |
|
2275
New Oriental
EDU
$9.11B
| $3.91M | ﹤0.01% |
192,064
-66,461
| -26% | -$910K |
|
Similar funds
David Shaw's Q2 2022 Portfolio in Review
As of Q2 2022, David Shaw held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
David Shaw withdrew a net $8.25B in Q2 2022, closing 791 positions and reducing 1,835 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in iShares MSCI Emerging Markets ETF worth $171M.
- David Shaw's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
- David Shaw added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
- David Shaw's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
- David Shaw fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
- David Shaw's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
- David Shaw opened 595 new positions and closed 791 in Q2 2022.
- David Shaw's portfolio value fell 20% quarter-over-quarter to $85.3B.
Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.